Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Orthocell Ltd ( (AU:OCC) ) has provided an update.
Orthocell Limited announced the issue of 3,000,000 unquoted options set to expire on October 31, 2027, with an exercise price of $0.67. This issuance is part of a previously announced transaction, which may impact the company’s financial strategy and offer stakeholders insights into its capital management plans.
More about Orthocell Ltd
Orthocell Limited is a company operating in the biotechnology sector, primarily focused on developing and commercializing regenerative medicine products to improve tissue repair and regeneration.
YTD Price Performance: 4.80%
Average Trading Volume: 1,527,492
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$340.4M
For a thorough assessment of OCC stock, go to TipRanks’ Stock Analysis page.